Cystourethroscopes

Welcome to Cystourethroscopes Site

Cystourethroscopes Resources

Home > Cystourethroscopes > [Neuroscience] Selective saturation of slow endocytosis at a giant glutamatergic central synapse lacking dynamin 1

[Neuroscience] Selective saturation of slow endocytosis at a giant glutamatergic central synapse lacking dynamin 1

Exocytosis of synaptic vesicles is rapidly followed by compensatory plasma membrane endocytosis. The efficiency of endocytosis varies with experimental conditions,...

Click Here to read the entire article...

Other Articles:

•	Aradigm Presents Phase 2 Data On Inhaled Liposomal Ciprofloxacin In Cystic Fibrosis At The North American Cystic Fibrosis Conference
	Aradigm Corporation (OTCBB: ARDM) it is presenting data from its Phase 2 study of inhaled liposomal ciprofloxacin (ARD-3100) in cystic fibrosis (CF) patients at the 22nd Annual North American Cystic Fibrosis (NACF) conference in Orlando, Florida. Completed in June 2008, the study was an open-label, two week efficacy and safety trial of once daily inhaled liposomal ciprofloxacin in 22 CF patients conducted at leading CF centers in Australia and New Zealand.
	Click Here to read the entire article...

•	Listen to The Lancet: 27 September
	An Editorial assesses the health-care policies of the two US presidential candidates, discussed by Faith McLellan in this week's podcast.
	Click Here to read the entire article...

•	The ASCB Needs You!
	Added a new document entitled The ASCB Needs You! This document outlines all of the opportunities that are available to you for volunteering.
	Click Here to read the entire article...

•

	Click Here to read the entire article...

•	Medtech Startups, January 2008
	New medical technologies represented in companies added (January 2008) to the Medtech Startups Database and/or added to the January 2008 issue of MedMarkets. The following are brief technology descriptions for companies newly added to the MedMarket Diligence Medtech Startups Database and/or covered in MedMarkets Startups during the month of December: Treatment of neurological and psychiatric disorders by, for example, electrical stimulation. Developing technologies to visualize vascular junctions in order to enhance ablation in treatment of atrial fibrillation. Technologies for embolic cerebral protection to reduce embolic stroke during interventional procedures. Ophthalmic technologies targeting vision loss. Developing a device for retro-muscular mesh placement in hernia repair. Femoral head resurfacing implant with internal fixation and instrumentation. Materials to enhance in situ tissue regeneration. Integrated insulin pump and glucose monitor for insulin-dependent diabetes. MRI-guided robotic breast cancer intervention. Nanoparticle-based delivery of chemotherapeutic agents for cancer. Ophthalmic device technologies. Device technologies to enhance left ventricular assist device (LVAD) implantation. Motion preserving spine fusion implant, inserted minimally invasively, for treatment of degenerative disc disease. Device technology to reduce incisions in laparoscopic surgery. Now Published!: Worldwide Wound Management 2007-2016. see link For coverage in specific issues of MedMarkets, see link. For details on the Medtech Startups Database, see link. Tags: medtech, startup
	Click Here to read the entire article...

•	'Prescription Switching' Would Make Most Patients Unhappy (HealthDay)
	HealthDay - THURSDAY, Nov. 6 (HealthDay News) -- Most prescription drug users would be unhappy if one of their medications was switched to another in the same class without their knowledge or their doctor's approval, a new survey shows.
	Click Here to read the entire article...